Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,234Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Reminyl

PharmaCompass

01

Brand Name : Reminyl

Galantamine Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

02

Brand Name : Reminyl

Galantamine Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

03

Brand Name : Reminyl

Galantamine Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

04

Brand Name : Reminyl

Galantamine Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Reminyl

arrow
2024 ACI Convention
Not Confirmed

Galantamine Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 155

2015 Revenue in Millions : 143

Growth (%) : 8

blank

05

Brand Name : Reminyl

Galantamine Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Reminyl

arrow
2024 ACI Convention
Not Confirmed

Galantamine Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 172

2016 Revenue in Millions : 165

Growth (%) : 4

blank

06

Brand Name : Reminyl

Galantamine Hydrobromide

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Reminyl

arrow
2024 ACI Convention
Not Confirmed

Galantamine Hydrobromide

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 150

2017 Revenue in Millions : 161

Growth (%) : -7%

blank